Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss With Metformin

Businesswire11/04 21:00

Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024

Businesswire11/01 20:00

Scholar Rock to Participate in Upcoming Investor Conferences

Businesswire11/01 04:00

Scholar Rock to Present New Clinical and Biomarker Data From the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting

Businesswire10/31 20:00

Top 2 Health Care Stocks That May Fall Off A Cliff This Month

Benzinga10/25 20:22

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Businesswire10/19 04:15